Sidus(TM) Post Market Clinical Follow-up (PMCF) Study
NCT01700543
Arthritis, Arthritis, Rheumatoid
Linz, Austria
View Trial DetailsNCT Number: NCT02350049
The purpose of this study is to evaluate the safety and effectiveness of the Cementless Oxford Partial Knee System.
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
The study is designed to document and compare the clinical and radiographic results of the Cementless Oxford Partial Knee System (investigational device) to those of the cemented Oxford Partial Knee System (control device).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 22+months
Radiographic Success, American Knee Society Score, Absence of Revision / Removal / Unanticipated Adverse Device Affects
Time frame: 22+ Months
Minimum 1,000 cases to assess survivorship of cementless components
Time frame: 0-16 Week, 6 Month, 12 Month
Assessment of Function and Range of Motion; retrospective study- data will be collected if available
Time frame: 0-16 Weeks, 6 Months, 12 Months, 22+ Months
Retrospective study; data will be collected if available.
Time frame: Through 22+ Months Postop
Zimmer Biomet
Industry
Cementless Oxford Partial Knee Retrospective and Prospective Controlled Multi-center Observational Study
Acronym: GK10
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01700543
Arthritis, Arthritis, Rheumatoid
Linz, Austria
View Trial DetailsNCT01285843
Arthritis, Avascular Necrosis
Dillingen an der Donau, Bavaria, Germany
View Trial DetailsNCT02096211
Arthritis, Avascular Necrosis
Sacramento, California, United States
View Trial DetailsNCT01820611
Arthritis, Arthritis, Rheumatoid
Turku, Finland
View Trial Details